3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Privigen: new trials by email Literature Review of Privigen trials Research Report on Privigen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT) Privigen, Thymoglobulin, Plasma Exchange - Kidney Transplantation | Phase 3 | Completed | Institute for Clinical and Experimental Medicine | 17 | 2020-07-27 | 2024-08-15 |
| Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis Immunoglobulins, Intravenous (Privigen), Placebo - Encephalitis | Phase 3 | Completed | University of Oxford | 18 | 2016-01-01 | 2024-03-04 |
| Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 Immunoglobulin Intravenous (Human) - Immune Thrombocytopenic Purpura | Phase 3 | Completed | CSL Behring | 58 | 2004-12-01 | 2011-11-23 |
Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Encephalitis (1) · Encephalomyelitis (1) · Meningoencephalitis (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Thrombocytopenia (1)
CSL Behring (1) · Institute for Clinical and Experimental Medicine (1) · University of Oxford (1)
United Kingdom (2) · Czechia (1) · Germany (1) · Italy (1) · Poland (1) · Russia (1) · Ukraine (1)
Andrew J Pollard, FRCPCH, PhD (1) · Ondrej Viklicky, Prof. (1) · Othmar Zenker, MD (1)
PMID 19635187, PMID 37945292, PMID 40458542
2004 (1)